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Study design: Retrospective cross-sectional database analysis.
Objective: The cost of spine surgery is growing exponentially, and cost-effectiveness is
a critical consideration. Smoking has been shown to increase hospital costs in general
surgery, but this impact has not been reported in patients with spinal disease. The
objective of this work was to evaluate the effect of smoking on cost and complications in
a large sample of patients admitted for treatment of spinal disease.
Methods: In 2012, the authors identified all inpatient admissions to all University
HealthSystemConsortium (UHC) hospitals from 2005 to 2011 for spinal disease based on
the principal diagnosis ICD-9-CM codes from the prospectively collected UHC database.
Patient outcomes – including length of stay; complication, readmission, intensive care
unit admission rates; and total cost – were compared for non-obese smokers and
non-smokers using a two-sample t-test.
Results: There were 137,537 patients, including 136,511 (122,608 non-smokers and
13,903 smokers) in the 4 largest diagnostic groups. Smoking was associated with
increased complications and worse outcomes in three of these four groups. All outcomes
in the two largest groups – fracture and dorsopathy – were worse in the smoking patients.
Conclusion: Smoking patients admitted for spinal disease in the sample had worse out-
comes, increased complications, and higher costs than their non-smoking counterparts.
In the current health-care climate focused on cost-effectiveness, smoking represents a
potentially modifiable area for cost reduction.
Keywords: smoking, spine, surgery, healthcare costs, value, modifiable risk factors, patient outcomes, quality
improvement
Introduction
Approximately 1.2million spinal surgeries are performed annually in theUnited States for traumatic,
oncologic, degenerative, and other conditions (1, 2). Fusion surgeries alone cost more than $10
billion, and the overall cost of spine care approaches $100 billion, accounting for nearly 10% of the
nation’s total healthcare expenditures (1, 2). While the annual increase in the cost of healthcare in
Abbreviations: ICU, intensive care unit; LOS, length of stay; UHC, University HealthSystem Consortium.
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general has been at its lowest recorded rates of the last 50 years, at
3.8 and 3.9%, respectively, for 2009 and 2010, spine care expen-
ditures as recently as 2005 were estimated to have increased 65%
from their 1997 levels (3). The reason for this exponential increase
remains unclear.
The shift over the last few decades to the use of more instru-
mentation in spinal surgery is well-documented, with increasing
numbers of both instrumented levels per spinal procedure and
spinal fusions altogether (4). Some have argued that the cost of
instrumentation has played a large role in the cost increase seen
for spinal surgery in the last decade, but there are likely to be
other potentially modifiable variables that affect the overall cost
of hospitalization for a patient with spinal disease. Recently, there
has been a call by the Institutes of Medicine (5) for research
on cost-effectiveness in many fields of medicine, including spine
surgery, to help define and improve value in medical care. To
address this call, the medical community will need not only to
identify the optimal treatment strategies based on cost-effective
studies but also to understand patient and hospital variables that
may impact the overall cost, bothmonetary and non-monetary, of
these procedures.
A recent review summarized the results from multiple studies
documenting the negative impact of smoking on the overall hos-
pital care of surgical patients, including increased risk of periop-
erative complications, morbidity, mortality, and admission to the
intensive care unit (ICU) in patients undergoing orthopedic, gen-
eral surgery, plastic surgery, and cardiac procedures (6–10). The
complications associated with smoking include wound infections,
delayed wound healing, pneumonia, and myocardial infarction
(9). Even pediatric surgery is affected, as pediatric patients with
more secondhand smoking exposure have been shown to have
higher rates of anesthesia-associated respiratory complications
(9). In addition to its impact on the medical care of patients,
smoking negatively affects costs associated with surgery. In 2012,
Kamath et al. (10) reported that among veterans undergoing gen-
eral surgical procedures, those who used tobacco had significantly
higher hospital-associated costs. With approximately 10 million
surgical procedures currently done on smokers in the United
States annually, including spinal procedures, it is imperative that
the contribution of this potentially modifiable risk to the overall
hospital cost of these procedures is defined (10).
As payment for the delivery of healthcare is changing, quality
improvement and cost reduction inmedical care are increasing on
the agenda for all healthcare institutions. The goal of this studywas
to evaluate the association of smokingwith cost and complications
in a large sample of patients admitted for spinal disease at both
academic and non-academic institutions using the prospectively
collected data in theUniversity HealthSystemConsortium (UHC)
database. Although the use of an administrative database limits
the ability to evaluate individual patient-level data, it nevertheless
provides the opportunity for a preliminary analysis that may be
the basis for future in-depth investigation.
Materials and Methods
UHC Database
The UHC is a network of 116 academic medical centers and
276 of their affiliated hospitals, comprising >90% of non-profit
academic medical centers in the country. The UHC database
contains demographic, financial, administrative, diagnostic, and
procedural information in addition to specific hospital stay infor-
mation such asmedication use, ICU admission rates/length of stay
(LOS), total hospital LOS, morbidity rates, mortality rates, com-
plications, and readmission rates (11, 12). The UHC database pro-
vides the ICD-9-CM code for almost every hospital discharge, and
although it was originally used for improving cost-effectiveness,
quality healthcare, safety, and overall outcomes through compar-
ing the variousmember institutions, multiple groups in other spe-
cialties, especially general surgery, have used this database to iden-
tify specific variables that impact outcomes (11–15). The patient
data set was de-identified before data gathering and therefore is
exempt from institutional review board approval.
Patient Population
In 2012, the authors queried the UHC database in a retrospective
cross-sectional analysis of all UHC hospitals from 2005 to 2011
to identify all inpatient admissions for treatment of spinal disease
based on the principal diagnosis ICD-9-CM codes, including cord
injury, congenital, curvature, dislocation, dorsopathy, which is
defined as “a condition in which there is a deviation from or
interruption of the normal structure or function of the spine,”
fracture, and sprains/strains. Obese patients (defined either by a
primary ICD-9-CM code of “obesity” or “morbid obesity” or by a
body mass index >25) were excluded because obesity is a known
independent risk factor for adverse outcomes and is associated
with increased cost, more complications, and higher infection
rates in spine surgery patients (16–19). The remaining non-obese
patientswith eachUHCdatabase diagnosis codewere then further
categorized as smokers or non-smokers. The primary aim of
this study was to evaluate whether smoking has an association
with either cost or quality-based outcomes in specific cohorts of
patients admitted with spinal disease as their principal diagnosis.
Outcomes
Primary outcomes were hospital LOS, ICU admission, 7-, 14-,
and 30-day readmission rates, complication rates, and total direct
cost associated with the hospital admission. Complications were
defined by ICD-9-CM code and included a list of 39 poten-
tial surgical complications, such as wound infection, myocardial
infarction, and urinary tract infection (see Appendix).
Statistical Analysis
The authors compared the outcomes for all non-obese spine
patients that were non-smokers with outcomes for smokers using
a two-sample t-test with a 95% confidence interval. Pooled vari-
ance was appropriate for almost all of the comparisons. Statistical
analysis was performed using SAS, Enterprise Guide Version 4.3.
Results
There were a total of 137,537 non-obese patients admitted
with spinal disease during the study period among all pathol-
ogy groups, including 136,511 total patients among the dor-
sopathy, fracture, curvature, and congenital groups, the four
largest cohorts. Approximately 10% of these were smokers
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TABLE 1 | Outcomes of patients admitted for spinal treatment for dorsopa-
thy.
Smoker Non-smoker p-Value
Mean LOS (days) 4.87 3.77 0.00
Mean ICU admission rate (%) 18 12 0.00
Mean complication rate (%) 6.97 5.24 0.00
Mean 7-day readmission rate (%) 2.80 2.04 0.00
Mean 14-day readmission rate (%) 4.84 3.28 0.00
Mean 30-day readmission rate (%) 6.89 4.81 0.00
Mean total cost ($) 23,185 18,889 0.00
LOS, length of stay; ICU, intensive care unit.
TABLE 2 | Outcomes of patients admitted for spinal treatment for fracture.
Smoker Non-smoker p-Value
Mean LOS (days) 19:13 14:37 0.00
Mean ICU admission rate (%) 71 58 0.00
Mean complication rate (%) 26:90 19:78 0.00
Mean 7-day readmission rate (%) 3:98 2:60 0.00
Mean 14-day readmission rate (%) 7:03 4:83 0.00
Mean 30-day readmission rate (%) 11:22 7:47 0.00
Mean total cost ($) 62,039 45,699 0.00
LOS, length of stay; ICU, intensive care unit.
(13,903) and almost 90% were non-smokers (122,608). The non-
smoking patients included 92,553 dorsopathy patients, 16,584
fracture patients, 1,962 congenital patients, and 11,509 curvature
patients, whereas the smoking patients included 11,384 dorsopa-
thy patients, 1,052 fracture patients, 228 congenital patients, and
1,239 curvature patients.
Statistical analysis demonstrated that smoking was associated
with increased complications and worse outcomes in three of the
four largest diagnosis groups. Smokers in the dorsopathy group
hadworse outcomes across allmeasured variableswhen compared
with non-smokers (Table 1), with a mean LOS that was 1.01 days
longer (p< 0.001), a 6% higher ICU admission rate (p< 0.001), a
complication rate that was 1.73% higher (p< 0.001), and a 0.76%
higher 7-day readmission rate (p= 0.00), a 1.56% higher 14-day
readmission rate (p< 0.001), and a 2.08% higher 30-day readmis-
sion rate (p< 0.001). Smoking patients in the fracture group also
had significantly worse outcomes across all measured outcomes
(Table 2), with a 4.76-day longer mean LOS (p< 0.001), a 13%
higher ICU admission rate (p< 0.001), a 7.12% higher complica-
tion rate (p< 0.001), and a 1.38% higher 7-day readmission rate
(p< 0.01), a 2.25% higher 14-day readmission rate (p< 0.01), and
a 3.75% higher 30-day readmission rate (p< 0.001). The smokers
in the congenital group hadworse LOS (0.57 days longer, p= 0.04)
and higher 30-day readmission rates (3.54% higher, p= 0.02),
but there was not a significant difference in the other measured
outcomes of ICU admission, complication rate, and 7- and 14-day
readmission rates (Table 3). Finally, the smokers in the curvature
group had worse 14-day (1.88% higher, p< 0.01) and 30-day
(3.04% higher, p< 0.001) readmission rates (Table 4), but there
was not a significant difference in the other measured outcomes.
Total hospital costs were significantly higher in smokers with
dorsopathy, congenital, and fracture as primary diagnosis codes
(Tables 1–3). The total hospital cost for patients with dorsopathy
TABLE 3 |Outcomes of patients admitted for spinal treatment for congenital
disease.
Smoker Non-smoker p-Value
Mean LOS (days) 4.91 4.34 0.04
Mean ICU admission rate (%) 14 10 0.09
Mean complication rate (%) 5.26 6.47 0.43
Mean 7-day readmission rate (%) 3.51 2.09 0.17
Mean 14-day readmission rate (%) 4.82 3.47 0.29
Mean 30-day readmission rate (%) 8.33 4.79 0.02
Mean total cost ($) 28,889 24,642 0.01
LOS, length of stay; ICU, intensive care unit.
TABLE 4 |Outcomes of patients admitted for spinal treatment for curvature.
Smoker Non-smoker p-Value
Mean LOS (days) 6:89 6:78 0.63
Mean ICU admission rate (%) 35 33 0.47
Mean complication rate (%) 12:35 11:94 0.68
Mean 7-day readmission rate (%) 3:13 2:46 0.15
Mean 14-day readmission rate (%) 6:46 4:58 0.00
Mean 30-day readmission rate (%) 10:17 7:13 0.00
Mean total cost ($) 40,674 39,850 0.51
LOS, length of stay; ICU, intensive care unit.
was $23,185 for smokers vs. $18,889 for non-smokers (p< 0.001).
Costs for smokerswith fractureswere $62,039while those for non-
smokers with fractures were $45,699 (p< 0.001), and the total
direct cost for smokers treated for congenital causes was $28,889
compared with $24,642 for non-smokers (p= 0.01).
Discussion
Despite abundant evidence documenting the negative impact of
smoking on surgical outcomes and cost, the literature document-
ing the negative association in patients with spinal disease is
scant. The authors present evidence of increased costs associated
with smoking in patients admitted for treatment of spinal disease.
Smoking in the dorsopathy and fracture groups was associated
with worse outcomes across all the study variables of LOS, ICU
admission, 7-, 14-, and 30-day readmission rates, complication
rates, and, ultimately, total direct cost. Patients in the congenital
group who smoked had also significantly longer LOS, increased
total direct cost, and higher 30-day readmission rates. Smokers
in the curvature group had higher 14- and 30-day readmission
rates when compared with non-smokers. The total direct cost of
care was also much higher in smoking patients, and the difference
was statistically significant for patients with dorsopathy, fracture,
and congenital disease with a difference of $4,296, $16,370, and
$4,247, respectively. In fracture patients, this increase in total cost
wasmore than 25% of the overall direct cost of the hospitalization.
Although an avalanche of research has documented the harm-
ful health effects of cigarette smoking, it remains the leading
preventable cause of morbidity and mortality in the U.S. and
accounts for 6–8% of national health-care costs (10, 20, 21). With
an estimated 30% smoking incidence among patients undergoing
elective general surgery, over 10 million surgical procedures are
performed on smokers annually in the U.S. (10). Smoking in
surgical patients has been shown to be associated with increased
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complication rates including increased mortality, wound infec-
tion, reoperation rates, ICU stay, overall LOS, 30-day mortality,
1-year mortality, and numerous other negative pulmonary, car-
diovascular, and wound healing effects (6, 8–10, 18, 20, 22–25),
all of which are associated with increased healthcare costs (10,
26–28).
The socioeconomic burden of spinal care, both operative and
non-operative, on healthcare costs is substantial (1). Smoking has
been shown repeatedly to lead to worse fusion rates and increased
surgical site infections (18, 29–31); however, some large studies
of hundreds of patients describing the effects of cigarette smoking
in spinal surgery have not found smoking to be associated with
negative outcomes or complications in the surgical treatment of
cervical spondylotic myelopathy, adult deformity surgery, decom-
pression/fusion in degenerative lumbar spinal stenosis,multi-level
cervical spine decompression, and anterior cervical spine surgery
(32–36). Nevertheless, a recent subset analysis of the SPORT
spinal stenosis cohort showed that all patient subgroups with
more than 50 patients improved with surgical treatment except
for smokers, as smoking was an independent risk factor for not
improving with surgical treatment (37). A separate large study
with 2-year follow-up of 4,555 patientswho underwent surgery for
lumbar spinal stenosis, with or without fusion, recently showed
that smokers were more likely to be dissatisfied with surgery,
used analgesics more regularly, and were less likely to have sig-
nificant improvement in ambulation (38). An additional study of
203 patients who had lumbar decompression and posterolateral
fusion found that smokers had less leg pain relief when compared
with their non-smoking counterparts (39). Lastly, a study of 23
patients also showed that, compared with smokers, non-smokers
had more postoperative relief of arm pain after anterior cervical
decompression and fusion with a specific fusion cage (40).
Given the deleterious effects of smoking on surgical patients, it
is not surprising that the benefits of perioperative smoking cessa-
tion, including improved surgical outcomes and fewer wound and
other postoperative complications, are well-documented in mul-
tiple studies and systematic reviews (9, 10, 41–45). Furthermore,
one orthopedic study evaluating total knee and hip arthroplasty
demonstrated perioperative smoking cessation led to an overall
reduction in the cost of care (22). Perioperative smoking cessation
is a unique opportunity to reduce complications and the overall
cost of healthcare, because surgery is one of the rare occasions
where continued smoking may cause immediate negative con-
sequences for the patient, in contrast to the typically delayed
consequences of smoking (9, 20). Spinal surgery provides a critical
opportunity since studies have shown that patients undergoing
major surgery, as opposed to an outpatient procedure, have rates
of smoking cessation as high as 35–50%, with some patients
continuing smoking cessation even after their recovery (20).
The most significant limitation of this study is the nature of
the data collection. The number of patients (>100,000) precludes
the data acquisition and subsequent analysis of specific individual
spinal pathology characteristics (e.g., radiographic extent of spinal
stenosis, symptom type/duration) other than the basic informa-
tion provided by the diagnostic ICD-9-CM codes, procedure
codes, and other easily tabulated patient history (e.g., presence or
absence of smoking, obesity). Although these characteristics could
have an effect on patient outcome and costs, the large patient num-
bers, coupled with the fact that there is no reason to believe that
the smoking and non-smoking patients were dissimilar enough to
skew the results, lends confidence to the results. Obese patients
were specifically excluded during the data acquisition so that the
pure effects of smoking could be seen without the results being
influenced by patient obesity, which is associated with increased
cost, complications, and infections in spinal surgery patients (16,
17, 19). The lower smoking rate observed in the patients in this
study (10 vs. 30% of all surgical patients) may be explained by the
exclusion of obese patients, as smokers have recently been shown
to have higher rates of obesity and diabetes, especially inmoderate
and heavy smokers (46, 47). The low smoker rate in this studymay
represent another limitation with respect to the generalizability of
these initial results.
Conclusion
Non-obese patients who smoke tobacco and were admitted to
UHC hospitals from 2005 through 2011 with spinal dorsopathy,
fracture, or congenital pathology had worse outcomes, more com-
plications, and higher total direct costs than their non-smoking
counterparts. The smokers in the curvature group also had higher
14- and 30-day readmission rates. This report also documents
increased cost associated with smoking tobacco in spine patients;
for smokers, the mean total cost for the four most common
spine pathologies is $38,697, whereas the same costs for a non-
smoker average $32,270 (p< 0.001). The Patient Protection and
Affordable Care Act’s emphasis on cost control and payment for
performance, in addition to the universal goal of providing the
best possible outcomes for patients, demands that surgeons advise
their potential spine surgery patients to enroll in formal smoking
cessation programs prior to consideration of surgery. Further
studies are necessary to better define the association between
smoking tobacco and worse outcomes in spine surgery patients.
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Appendix
TABLE A1 | Complications per 1,000 patient encounters for spinal disease
2005–2011.
Complication description Rate
per 1,000
Postoperative pulmonary compromise 38:97
Mechanical complications due to device or implant 27:62
Other complications of procedures 24:61
Aspiration pneumonia 15:96
Venous thrombosis/pulmonary embolism 12:42
Nosocomial pneumonia 15:87
Miscellaneous complications 12:32
Sepsis 10:77
Wound infection 9:90
Post-procedure hemorrhage or hematoma 9:07
Acute myocardial infarction occurring during hospital stay 7:27
Procedure-related perforations or lacerations 6:38
Cellulitis or decubitus ulcer 5:18
Reopening of surgical site 4:47
Postoperative stroke 4:13
Gastrointestinal hemorrhage 4:04
Central or peripheral nervous system 3:85
Postoperative infections not pneumonia/wound 3:28
Catheter-associated urinary tract infection 1:49
Postoperative urinary tract complication 1:17
Postoperative cardiac abnormality except acute myocardial infarction 0:82
Hospital-acquired C. diff enteritis 0:69
Postoperative coma or stupor 0:58
Adverse events due to anesthesia 0:36
Postoperative physical and metabolic derangements 0:23
Readmission for infection due to previous care 0:22
Infection/inflammation due to internal device, implant, graft 0:14
Readmission for other complications of internal device, implant, graft 0:07
Shock or cardiorespiratory arrest 0:03
Post- or intraoperative shock due to anesthesia 0:01
Rates for complications with rates >1 per 100,000.
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